Compare NEXN & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEXN | QTRX |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.2M | 337.7M |
| IPO Year | 2021 | 2017 |
| Metric | NEXN | QTRX |
|---|---|---|
| Price | $6.46 | $7.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $12.13 | $10.33 |
| AVG Volume (30 Days) | 434.2K | ★ 875.4K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 237.45 | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $376,353,000.00 | $130,203,000.00 |
| Revenue This Year | $5.43 | N/A |
| Revenue Next Year | N/A | $28.28 |
| P/E Ratio | $10.41 | ★ N/A |
| Revenue Growth | ★ 7.80 | N/A |
| 52 Week Low | $6.08 | $4.05 |
| 52 Week High | $12.60 | $12.94 |
| Indicator | NEXN | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 71.38 |
| Support Level | $6.35 | $6.70 |
| Resistance Level | $6.71 | $7.89 |
| Average True Range (ATR) | 0.26 | 0.46 |
| MACD | 0.06 | 0.14 |
| Stochastic Oscillator | 29.70 | 89.45 |
Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and advanced TV that helps empower advertisers, agencies, digital publishers and broadcasters to achieve desired outcomes, including increased efficiency and returns, across the media supply chain. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. Company operates in America, APAC, EMEA, regions, with majority revenue from America.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.